Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease

Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease

Show other versions (1)

<h4>Background</h4> Dual antiplatelet therapy (DAPT) is currently the standard treatment for the prevention of ischemic events after stent implantation. However, the optimal DAPT duration remains elusive for patients with chronic kidney disease (CKD). Therefore, we aimed to compare the e...

Full description

Bibliographic Details
Main Authors: Chih-Chin Kao, Mai-Szu Wu, Ming-Tsang Chuang, Yi-Cheng Lin, Chun-Yao Huang, Wei-Chiao Chang, Chih-Wei Chen, Tzu-Hao Chang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336855/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336855/?tool=EBI

Similar Items